Hims & Hers Health, Inc. (HIMS) is a telehealth company focused on providing personalized and accessible healthcare solutions for a wide range of conditions. Through its direct-to-consumer platform, Hims & Hers connects individuals with licensed healthcare providers for consultations and prescriptions, offering convenience and privacy. The company aims to make high-quality healthcare more approachable by […]
Read MoreThe biopharmaceutical and biotechnology sector continues to make significant strides in developing therapies and medical advancements. Companies like Mesoblast Limited (MESO), Nurix Therapeutics, Inc. (NRIX), and Eledon Pharmaceuticals, Inc. (ELDN) are driving innovation in treatments for complex diseases, utilizing advanced scientific approaches to improve patient outcomes. Mesoblast Limited (MESO) is a biopharmaceutical company focused on […]
Read MoreFeatured Content BrainsWay Ltd. (BWAY) is a medical device company focused on developing and commercializing innovative treatments for brain disorders using its proprietary Deep Transcranial Magnetic Stimulation (dTMS) technology. Founded in 2003 and headquartered in Jerusalem, Israel, BrainsWay aims to provide non-invasive therapies for a variety of mental health conditions, including depression, obsessive-compulsive disorder (OCD), […]
Read MoreFeatured Content Bioventus Inc. (BVS) Bioventus Inc. is a medical device company focused on developing products that enhance healing and improve the quality of life for patients. Its portfolio includes orthobiologics, joint therapies, and surgical solutions. The company prioritizes innovation and clinical evidence to advance patient care and outcomes. Bioventus is continually expanding its product […]
Read MoreFeatured Content Bioventus Inc. (BVS) Bioventus is a medical device company focused on developing products that enhance healing and improve the quality of life for patients. Its portfolio includes offerings in orthobiologics, joint therapies, and surgical solutions. The company emphasizes innovative solutions that promote bone healing and reduce recovery times for patients worldwide. In addition […]
Read MoreFeatured Content Pulse Biosciences, Inc. is a cutting-edge medical technology company that focuses on developing and commercializing innovative healthcare solutions using its proprietary Nano-Pulse Stimulation™ (NPS) technology. Based in Hayward, California, Pulse Biosciences is pioneering a new category of energy-based therapies designed to treat a variety of skin conditions, tumors, and other diseases by delivering […]
Read MoreThe Real Brokerage Inc. (REAX) The Real Brokerage Inc., together with its subsidiaries, operates as a real estate technology company in the United States and Canada. It operates in three segments: North American Brokerage, Real Title, and One Real Mortgage. TransMedics Group, Inc. (TMDX) TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant […]
Read MoreCareDx, Inc. is a precision medicine company focused on discovering, developing, and commercializing clinically differentiated, high-value diagnostic solutions for transplant patients. The company’s flagship product, AlloSure, is a non-invasive blood test that measures donor-derived cell-free DNA, providing insights into organ rejection in kidney transplant recipients. CareDx also offers AlloMap, a blood test for heart transplant […]
Read MoreMerit Medical Systems, Inc. is a global manufacturer and marketer of medical devices used in various interventional, diagnostic, and therapeutic procedures. The company’s innovative product portfolio includes devices and equipment for cardiology, radiology, oncology, and critical care, as well as products for medical imaging and endoscopy. Merit Medical is known for developing proprietary technologies and […]
Read MoreSoleno Therapeutics, Inc. (SLNO) Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Larimar Therapeutics, Inc. (LRMR) Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Summit Therapeutics Inc. (SMMT) Summit Therapeutics […]
Read MoreDyne Therapeutics, Inc. (DYN) is a clinical-stage biotechnology company focused on developing transformative therapeutics for people living with serious muscle diseases caused by genetic mutations. The company is headquartered in Waltham, Massachusetts, and leverages its proprietary FORCE™ platform to create innovative oligonucleotide therapeutics designed to deliver drugs directly to muscle tissue, thereby overcoming significant challenges […]
Read MorePetIQ, Inc. is a prominent player in the pet health and wellness industry, providing a wide array of products and services that cater to the needs of pet owners. Headquartered in Eagle, Idaho, PetIQ focuses on making pet health care more accessible and affordable. The company operates through two main segments: Products and Services. The […]
Read MoreTransMedics Group, Inc. is a leading medical technology company focused on transforming organ transplantation. The company is headquartered in Andover, Massachusetts, and it specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. This technology is designed to preserve the quality of organs, assess their viability before transplant, and potentially increase the […]
Read MoreHeron Therapeutics, Inc. (HRTX) is a biotechnology company focused on improving the lives of patients by developing novel, patient-focused therapeutic solutions. The company specializes in treatments for cancer and pain management. Heron’s key products include Sustol, an extended-release injectable designed to prevent chemotherapy-induced nausea and vomiting (CINV), and Cinvanti, an intravenous formulation that also targets […]
Read MoreVera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase III clinical trial for patients with immunoglobulin A nephropathy; and for treatment of lupus nephritis that is […]
Read More